4:20 PM
 | 
Jul 11, 2018
 |  BC Extra  |  Company News

Novartis drops antibiotic, antiviral research

Novartis AG (NYSE:NVS; SIX:NOVN) is exiting antibacterial and antiviral research, according to an emailed statement from the company.

The pharma plans to cut headcount at the Emeryville, Calif., campus of Novartis Institutes for BioMedical Research (NIBR) by about 140...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >